- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03960684
Study of Colorectal Procedures With the Levita Magnetic Surgical System
Prospective Study of Colorectal Procedures With the Levita Magnetic Surgical System
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Santiago, Chile
- Hospital del Salvador
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subject is at least 18 years of age
- Subject is scheduled to undergo elective colorectal surgery
Exclusion Criteria:
- Significant comorbidities
- Subjects with pacemakers, defibrillators, or other electromedical implants
- Subjects with ferromagnetic implants
- Clinical history of impaired coagulation
- Subject has an anatomical abnormality noted after initiation of index procedure that would prevent device use
- Subject is not likely to comply with the follow-up evaluation schedule
- Subject is participating in another clinical trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Levita Magnetic Surgical System
|
Levita Magnetic Surgical System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number and Types of Tools Required to Retract the Colon or Peri-colorectal Tissues
Time Frame: During planned colorectal procedure
|
Ability to adequately retract the colon, peri-colorectal tissues or adjacent organs to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract these tissues during the procedure. Cumulative number of additional tools required across all participants. |
During planned colorectal procedure
|
|
Device Related Adverse Events
Time Frame: Through 30 days post colorectal procedure/study completion.
|
All adverse events will be recorded and allocated as to relatedness to device, procedure or other.
|
Through 30 days post colorectal procedure/study completion.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: I. Emre Gorgun, MD, The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CP006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Procedures
-
Ethicon Endo-SurgeryTerminatedColorectal Surgical ProceduresUnited States
-
Ethicon Endo-SurgeryCompletedPediatric Procedures | Adult Hepato-pancreato-biliary (HPB) Procedures | Adult Lower Gastrointestinal Procedures | Adult Gastric Procedures | Adult Gynecological Procedures | Adult Urological Procedures | Adult Thoracic ProceduresUnited States, Canada, United Kingdom
-
Ethicon Endo-SurgeryRecruitingAdult Gynecological Procedures | Adult Urological Procedures | Adult Thoracic Procedures | Pediatric Surgical Procedures | Adult Surgical ProceduresCanada, United Kingdom, United States
-
Ethicon Endo-SurgeryCompletedGastric Procedures | Lung Resection ProceduresUnited States
-
Medizinische Hochschule Brandenburg Theodor FontaneIntuitive FoundationActive, not recruitingRobotic Surgical Procedures | Outcome Assessment | Colorectal Cancer (CRC) | Laparoscopic Abdominal Surgery
-
MedtronicCompletedSurgical Procedures, Operative | Minimally Invasive Surgical ProceduresUnited States
-
Samsung Medical CenterCompletedSternotomy | Cardiac Surgical Procedures | Thoracic Surgical ProceduresKorea, Republic of
-
Healthpoint HospitalUnknownOrthopedic Procedures
-
Christie Medical Holdings, Inc.Completed
-
University Health Network, TorontoPhilips HealthcareUnknownEndovascular ProceduresCanada
Clinical Trials on Levita Magnetic Surgical System
-
Levita MagneticsActive, not recruitingUpper Gastrointestinal Laparoscopic SurgeryChile
-
Levita MagneticsCompleted
-
Levita MagneticsCompletedBariatric Surgery CandidateChile
-
Foregut Research FoundationTerminatedHiatal Hernia Large | Gastro Esophageal Reflux | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Reflux, Gastroesophageal | Reflux AcidUnited States
-
National Taiwan University HospitalInsight Medical SolutionsCompleted
-
Damascus UniversityCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer American Joint Committee on Cancer v8United States
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaWithdrawn
-
University Hospital, GhentBioElectronics CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate AdenocarcinomaUnited States